Liquidia Technologies, Inc. (LQDA): Price and Financial Metrics

Liquidia Technologies, Inc. (LQDA): $13.29

0.52 (-3.77%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

LQDA Price/Volume Stats

Current price $13.29 52-week high $16.99
Prev. close $13.81 52-week low $5.71
Day low $12.85 Volume 829,300
Day high $13.97 Avg. volume 941,996
50-day MA $14.71 Dividend yield N/A
200-day MA $9.79 Market Cap 1.01B

LQDA Stock Price Chart Interactive Chart >


Liquidia Technologies, Inc. (LQDA) Company Bio


Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865, which completed Phase Ib clinical trials for the treatment of local post-operative pain. The company was founded in 2004 and is based in Morrisville, North Carolina.


LQDA Latest News Stream


Event/Time News Detail
Loading, please wait...

LQDA Latest Social Stream


Loading social stream, please wait...

View Full LQDA Social Stream

Latest LQDA News From Around the Web

Below are the latest news stories about LIQUIDIA CORP that investors may wish to consider to help them evaluate LQDA as an investment opportunity.

Biotech CEOs Are Buying Up Their Surging Stocks

Shares of Cibus, OmniAb, and Liquidia—three small biotechs—have seen big gains this year. Their CEOs just bought more stock.

Yahoo | December 25, 2023

Peabody Energy, Janus International, and More Stocks See Action From Activist Investors

Activists file with the SEC on Liquidia, Janus International Group, Peabody Energy, Disc Medicine, and Blue Bird.

Yahoo | December 22, 2023

Industry Analysts Just Upgraded Their Liquidia Corporation (NASDAQ:LQDA) Revenue Forecasts By 38%

Liquidia Corporation ( NASDAQ:LQDA ) shareholders will have a reason to smile today, with the analysts making...

Yahoo | December 22, 2023

Independent Director of Liquidia Picks Up 5.3% More Stock

Those following along with Liquidia Corporation ( NASDAQ:LQDA ) will no doubt be intrigued by the recent purchase of...

Yahoo | December 21, 2023

U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)

Liquidia will pursue final FDA approval for YUTREPIA™ (treprostinil) inhalationLiquidia will immediately request that District Court set aside injunction tied to ‘793 patent MORRISVILLE, N.C., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced that the U.S. Court of Appeals for the Federal Circuit (Federal Circuit) today affirmed the earlier decision by the Patent Trial and Appeal Board (PTAB) which found all claims of U.S. Patent No. 10,716

Yahoo | December 20, 2023

Read More 'LQDA' Stories Here

LQDA Price Returns

1-mo -18.17%
3-mo 3.10%
6-mo 117.16%
1-year 91.50%
3-year 359.86%
5-year 56.91%
YTD 10.47%
2023 88.85%
2022 30.80%
2021 65.08%
2020 -30.99%
2019 -80.26%

Continue Researching LQDA

Want to see what other sources are saying about Liquidia Technologies Inc's financials and stock price? Try the links below:

Liquidia Technologies Inc (LQDA) Stock Price | Nasdaq
Liquidia Technologies Inc (LQDA) Stock Quote, History and News - Yahoo Finance
Liquidia Technologies Inc (LQDA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!